VERANOVA LP

Overview

VERANOVA LP is an active pharmaceutical ingredient (API) supplier with 61 active FDA Type II Drug Master Files, covering 4116.E; 4235.D; 4237.G; 4245.C (MILLED) [DOFETILIDE]; 4250.B (ETHACRYNIC ACID); 4302.E.

API / Drug Master Files

VERANOVA LP holds 61 active (62 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LISDEXAETAMINE DIMESYLATE B1625Active2023-10-20
• LENALIDOMIDEActive2022-05-12
• SODIUM OXYBATE AQUEOUS CONCENTRATEActive2022-02-18
• RACEMIC AMPHETAMINE ASPARTATEActive2020-01-31
• LURASIDONE HCLActive2020-01-31
• OXYCODONE BASEActive2019-10-14
• CANNABIDIOLActive2018-08-10
• PIRFENIDONEActive2018-03-30
• NINTEDANIB ESYLATEActive2018-03-29
• OXYCODONE HCLActive2018-03-16
• ROFLUMILASTActive2017-10-31
• 4303.BActive2016-12-21
• 4302.EActive2016-06-01
• SILODOSINActive2016-05-31
• 4250.B (ETHACRYNIC ACID)Active2016-02-18

Showing 15 of 62 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to VERANOVA LP in our records. PharmaTek screens the full directory against live FDA enforcement data.